Impacts / Research Outputs

In progress

2024

Our Data Sources as a Strategic National Asset by Te Rourou Tātaritanga, and Social Wellbeing Agency.

2023

iNZight development for GUiNZ by Tom Elliott, Andrew Sporle, GUiNZ Data Access Team, Chris Wild, Barry Milne, and Colin Simpson.

2022

Library of data indicators by Social Wellbeing Agency.
Use of Population-Level Administrative Data in Developmental Science by Barry Milne, D'Souza S, Andersen S, and Richmond-Rakerd L.
Data Ethics, Privacy, and Governance Workshop - A summary report by Te Rourou Tātaritanga, and Social Wellbeing Agency.
IDI Exemplar Project by Social Wellbeing Agency.
Definitions from vaccination uptake project by Social Wellbeing Agency.

2021

Digitizing Birth Records for Intergenerational Research by Barry Milne, Eileen Li, Andrew Sporle, Colin Simpson, Leah Richmond-Rakerd, Terrie Moffitt, Avshalom Capsi, and Stephanie D'Souza.

2020


Related research by programme researchers

2024

2023

A better start national science challenge: Supporting the future wellbeing of our tamariki E tipu, e rea, mō ngā rā o tō ao: grow tender shoot for the days destined for you. by Maessen SE, Taylor BJ, Gillon G, Moewaka Barnes H, Firestone R, Taylor RW, Barry Milne, Hetrick S, Cargo T, McNeil B, and Cutfield W.

2022

New Zealand Socio-economic Index 2018 by Boven N, Shackleton N, Bolton L, Andrew Sporle, and Barry Milne.

2021

COVID-19 vaccine strategies for Aotearoa New Zealand: a mathematical modelling study by Nguyen T, Adnan M, Binh Nguyen, de Ligt J, Geoghegan J, Dean R, Jefferies S, Baker M, Seah W, Andrew Sporle, Fench N, Murdoch D, Welch D, and Colin Simpson.
Māori and Pacific People in New Zealand have higher risk of hospitalisation for COVID-19 by Steyn N, Binny RN, Hannah K, Hendy S, James A, Lustig A, Ridings K, Plank MJ, and Andrew Sporle.
Do socially isolated children become socially isolated adults? by Lay-Yee R, Matthews T, Moffitt T, Poulton R, Caspi A, and Barry Milne.

2020

Genomic epidemiology reveals transmission patterns and dynamics of SARS-CoV-2 in Aotearoa New Zealand by Geoghegan JL, Ren X, Storey M, Hadfield J, Jelley L, Jefferies S, Sherwood J, Paine S, Huang S, Douglas J, Mendes FK, Andrew Sporle, Baker MG, Murdoch DR, French N, Colin Simpson, Welch D, Drummond AJ, Holmes EC, Duchene S, and de Ligt J.
Use of Genomics to Track Coronavirus Disease Outbreaks, New Zealand by Geoghegan JL, Douglas J, Ren X, Storey M, Hadfield J, Silander OK, Freed NE, Jelley L, Jefferies S, Sherwood J, Paine S, Huang S, Andrew Sporle, Baker MG, Murdoch DR, Drummond AJ, Welch D, Colin Simpson, French N, Holmes EC, and de Ligt J.
Medication dispensing for Attention-Deficit/Hyperactivity Disorder to New Zealand youth by D’Souza S, Bowden N, Gibb S, Shackleton N, Audas R, Hetrick S, Taylor B, and Barry Milne.
Estimated inequities in COVID-19 infection fatality rates by ethnicity for Aotearoa New Zealand by Steyn N, Binny RN, Hannah K, Hendy SC, James A, Lustig A, McLeod M, Plank MJ, Ridings K, and Andrew Sporle.
Genomic evidence supports in-flight transmission of SARS-CoV-2 despite pre-departure testing by Tara Swadi, Jemma L Geoghegan, Tom Devine, Caroline McElnay, Jillian Sherwood, Phil Shoemack, Xiaoyun Ren, Matt Storey, Sarah Jefferies, Erasmus Smit, James Hadfield, Aoife Kenny, Lauren Jelley, Andrew Sporle, Andrea McNeill, G Edwin Reynolds, Kip Mouldey, Lindsay Lowe, Gerard Sonder, Alexei J Drummond, Sue Huang, David Welch, Edward C Holmes, Nigel French, Colin Simpson, and Joep de Ligt.